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Background: Atherosclerotic cardiovascular disease (ASCVD) is a growing public health 
threat globally, and many individuals remain undiagnosed, untreated, and their condition remains 
uncontrolled. The key to effective ASCVD management is adherence to pharmacotherapy, and 
non-adherence has been associated with an increased risk of cardiovascular events and compli-
cations such as stroke, further impacting a patient’s ability to be adherent. Our qualitative study 
aimed to explore factors influencing medication adherence in the primary and secondary preven-
tion of ASCVD in Singapore. We propose a synthesized framework, which expands on current 
understandings of the factors of medication adherence, as a frame of analysis in this study.
Methods: We conducted in-depth, semi-structured interviews with 20 patients over the age 
of 40 with ASCVD and/or its risk factors in Singapore. QSR Nvivo 11 was used to conduct 
thematic analysis using an inductive approach.
Results: Using a synthesized framework, we reported that complex medication regimens, the 
lack of support received during regimen changes, and the perceived seriousness of a condi-
tion could impact a patient’s medication adherence. Key findings suggest that the relationship 
between health care professionals and patients impacted patient acceptability of the medication 
regimen and consequently medication adherence. Different patient beliefs regarding diagnosis, 
medication, and adherence had some bearing on the ability to perceive the need to adhere to their 
medication. Patients also reported that they could afford medication, sometimes with the help 
of family members. Patients also largely reported not needing help managing their medication, 
considering it an individual responsibility.
Conclusion: We identified key factors which future interventions looking to improve medica-
tion adherence ought to consider. These include changing patient perceptions of health systems, 
diagnosis, medication, and adherence; patient-centeredness in developing interventions that 
facilitate adherence through building self-efficacy and stronger support networks via patient 
empowerment and engagement; decreasing patient co-payments on medication; and cultivating 
a trusting patient–provider relationship.
Keywords: atherosclerotic cardiovascular disease, medication adherence, access, qualitative 
research, Singapore
Introduction
Cardiovascular disease (CVD), including atherosclerotic cardiovascular disease 
(ASCVD) such as ischemic heart disease, stroke, and peripheral vascular disease, are 
leading causes of mortality worldwide.1 The recent Global Burden of Disease study 
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estimates 422.7 million prevalent cases of CVD, with CVD 
being accountable for one third of all deaths.2 The World 
Heart Federation estimates there will be over 23 million 
deaths from CVD by 2030 and that many CVD cases are 
preventable by addressing behavioral risk factors.3 Further, 
evidence has shown that Asian countries face higher age-
adjusted mortality from CVD.4 In 2016, 39.5% of total deaths 
in Singapore were due to CVD.5
ASCVD risk factors such as hyperlipidemia, hyperten-
sion, and/or prior ASCVD contribute to future ASCVD risk, 
which necessitates primary and secondary cardiovascular 
prevention.6–8 A key component of secondary CVD preven-
tion is the use of pharmacotherapy, which has been shown 
to mitigate the risk of developing ASCVD and associated 
complications.7,9 Medication adherence is crucial to the 
effectiveness of pharmacotherapy for CVD;10–12 however, 
evidence shows that patient non-adherence to medications 
for chronic conditions such as ASCVD is common.12,13 Such 
non-adherence to medication has been associated with the 
occurrence of cardiovascular events among patients with 
CVD,14 as well as increasing the risk of complications such 
as stroke, which could further impact a patient’s ability to 
be adherent.10,15
Several studies have illustrated issues associated with 
medication non-adherence, such as poor patient outcomes 
and the burden it places on the health care system.16,17 Several 
factors have been found to underpin issues associated with 
medication non-adherence such as, the type of medica-
tion prescribed,18,19 low socioeconomic status,14 treatment 
complexity,20 marital status,19 treatment side effects,21 and 
health system factors.15,22 Given these challenges, there has 
been a call for interventions to support medication adherence 
that consider the patient’s role within the context of the health 
system.16 As such, there is a need for innovative ways to 
better enable patients to take their medications, particularly 
in health systems like Singapore, where coverage and health 
system usage are high and the effectiveness of a treatment 
is largely dependent on medication adherence.14
Mobile health (mHealth) interventions for CVD preven-
tion have shown promising results in promoting medication 
adherence for stroke,23 hypertension,24 and heart failure.25,26
This paper focuses on Singapore, where, given high rates 
of mobile phone use,27,28 mHealth interventions have the 
potential to be successful in promoting medication adherence. 
The current study is the development phase of a proposed 
mHealth intervention to support patient adherence to ASCVD 
and hypertension medication among a diverse, elderly Sin-
gaporean population. Integral to the development of this 
intervention is the need for an understanding of the various 
factors contributing to the experience of medication (non-)
adherence among patients with ASCVD. Thus, our qualitative 
study aimed to explore factors influencing medication adher-
ence in the primary and secondary prevention of ASCVD in 
Singapore by delving into the experience of patients.
Conceptual framework
In this paper, our approach to conceptualizing medication 
adherence has been informed by the WHO’s five dimensions 
of adherence, as well as Levesque’s conceptualization of 
patient-centered access.6,29
Based on a review of the literature, the dimensions 
describe the various factors impacting on adherence, ranging 
from the personal to system level factors. The WHO dimen-
sions do not operate as separate factors, but rather interplay 
with each other to impact patient adherence to medication. 
However, while these dimensions are useful, a more detailed 
description of each concept within a dimension is needed 
to provide a comprehensive understanding of the factors 
influencing patients’ adherence to treatment. For example, 
health system factors such as the lack of health care financing 
need to consider socioeconomic factors such as the patient’s 
ability to pay for health care in light of other expenses in 
order to truly understand its impact on a patient’s adherence. 
Thus, we found that an important element not sufficiently 
highlighted in the current WHO framework is access, which 
has been shown to impact a patient’s adherence to treatment.30 
Access is particularly important as it helps us see how the 
dimensions of health system, patient, and socioeconomic 
factors truly interplay with each other to impact a patient’s 
adherence to treatment.
Levesque et al define access as “the opportunity to reach 
and obtain appropriate health care services in situations of 
perceived need for care”.29 The authors conceive access as 
both the accessibility of services to realize such an oppor-
tunity, as well as the ability of patients to interact with such 
accessibility.
Accessibility is conceptualized in five dimensions, 
approachability, acceptability, availability, affordabil-
ity, and appropriateness. Correspondingly, there are five 
abilities that enable the patient to engage with accessibility 
including ability to perceive, seek, reach, pay, and engage, 
respectively.
To better understand the many factors acting upon 
patients, we have integrated the two frameworks (WHO 
framework of adherence and Levesque’s framework for 
health care access) to form the conceptual basis of this paper. 
Integrating these frameworks allows for exploration of nuance 
in the dimensions of adherence conceived by the WHO, and 
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greater consideration of the role of access in patient adher-
ence. Although Levesque et al conceived the framework in 
the context of health system access, in this paper, we used 
their framework more narrowly to explore medication access 
and its impact on medication adherence. While traditionally 
medication access refers to the process of physically obtain-
ing medication,31,32 we used Levesque et al’s understanding 
of health system access to frame medication access as the 
interaction of accessibility and ability (Figure 1).
This synthesized framework was conceptualized with a 
mix of inductive approaches from thematic analysis of the 
data and deductive approaches based on our aim to explore 
factors which have bearing on access and adherence. Such a 
framework is important to understand the interface of health 
system, social, economic, and patient related factors, as well 
as to foster a deeper understanding of the complex relation-
ship between health system and patient in enabling medication 
adherence. Such an understanding not only allows for greater 
granularity in exploring factors related to medication adher-
ence but also accounts for patients’ perspectives, which has 
been lacking in the conception of previous adherence inter-
ventions and models of understanding health behaviour.14,16 
For example, the health belief model which has traditionally 
been a cornerstone to help health systems predict why people 
take action, to screen, prevent, and manage their illnesses, has 
tended to focus on patient beliefs as the key to encouraging 
better self management of illnesses.33 However such a view 
overlooks two key points. Firstly, it overlooks how structures 
such as social financing, health financing, or socioeconomic 
factors might impact how beliefs are conceived. Secondly, 
it makes an implicit assumption that health beliefs manifest 
into practice, which might not be the case and points to the 
clear need for an understanding of access to develop a more 
nuanced approach. Insights derived from this framework can 
inform the development of comprehensive adherence inter-
ventions, such as the proposed mHealth intervention.
Methods
sampling
The study took place in Singapore, and we used purposive 
sampling from an existing patient list to recruit those aged 
40 years and above with established ASCVD, or at least one 
risk factor for ASCVD (Box 1 includes complete inclusion 
and exclusion criteria).
in-depth interviews
Trained staff and students from the National University of 
Singapore conducted semi-structured in-depth interviews 
in the participant’s preferred language (by staff fluent in 
that language). Interviewer training included description of 
research protocol, qualitative methods, and research ethics 
in practice.
The interview guide was developed as part of the larger 
txt2heart collaboration (an international collaboration 
evaluating the effectiveness of mHealth for secondary pre-
vention), which we then adapted to the Singapore context 
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Figure 1 integrating the WhO dimensions of adherence with levesque’s health system access framework.
Abbreviation: hcP, health care personnel.
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and covered topics including patients’ sociodemographic 
characteristics, health care access, medication adherence, 
mobile phone technology usage (ownership, access, and 
utilization), and interest in mHealth (Table 1).
Analysis
This study was grounded within interpretative approaches, in 
which interviews are believed to provide access to accounts 
of how respondents perceive, understand, and talk about the 
Box 1 study inclusion and exclusion criteria
Inclusion criteria:
1. Patients with a history of atherosclerotic cardiovascular disease 
(AscVD): coronary artery disease, ischemic stroke, peripheral 
artery disease, and atherosclerotic aortic disease; Or
2. at least one risk factor such as hypertension or hyperlipidemia; 
in whom antiplatelet, antihypertensives, and/or statins are 
recommended.
Exclusion criteria:
1. Participants unable to participate in a verbal interview;
2. and those who did not speak Mandarin, english, or Malay languages.
Table 1 summary interview guide
Introductory questions
•	 Take demographic information
•	 To start, could you tell us a bit about your family?
•	 can you tell me a bit about your living situation? do you live with anyone? who?
•	 Are you currently employed?
•	 Does anyone help you with your daily tasks like chores or cooking?
Medical history and perception of condition
•	 could you tell me about your health history (or medical conditions you have)? [Follow their narrative to explore the patients’ journey]
•	 can you tell me about how you were diagnosed with cardiovascular/heart disease?
•	 could you share with me the changes you had to make in daily life after you were diagnosed with cVD/heart disease?
•	 What do you think contributed to your cVD/heart disease?
•	 What did you know about cVD/heart disease before you were diagnosed?
Perception and taking medication
•	 could you share with us all the medicine you currently take? [Ask if it is possible for us to see the medication, and ask about when and how 
often they take it]
•	 What instructions were you given on how to take the medication?
•	 Do you feel like taking the medication helps to relieve your condition?
•	 Do you take your medication regularly?
•	 Do you experience any problems in taking the medication?
•	 Do you ever forget to take your medicine?
•	 Does anyone or anything remind you to take your medication?
Health system perception
•	 Moving on, can you tell me about where you go to see the doctor for your cVD/heart disease?
•	 how often do you see your doctor?
•	 Overall, what is your relationship with your doctor like?
•	 Do you talk to any other health care workers about your cVD/heart disease? nurses? counselors? can you tell me about your relationship with them?
•	 Do you face any difficulties accessing health services?
•	 how do you pay for your medical expenses?
•	 Do you have any problems affording your cVD/heart disease medication?
Support and information networks
•	 Where do you seek information about how to manage your cVD/heart disease?
•	 What kind of information?
•	 Do you use this information frequently?
•	 Do you feel like you have enough information to help you manage your cVD/heart disease?
•	 Does anyone help you manage your cVD/heart disease?
Use and appropriation of technology
•	 Do you own a mobile phone?
•	 how often do you use your mobile phone?
•	 What do you usually use your mobile phone for?
•	 Do you experience any difficulties using your mobile phone?
•	 Would you find it useful to receive information about different aspects of your treatment through your mobile phone?
•	 Would you find it useful to receive reminders to take your medication through your mobile phone?
•	 how often would you like to receive such reminders?
•	 Would you like the possibility of being able to reply to these messages, where health care professionals can respond to your queries?
Abbreviation: cVD, cardiovascular disease.
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world. Two research team members coded interviews using 
QSR Nvivo 11 Software, applying inductive approaches, 
thematic analysis, and techniques from the constant com-
parative method, where line-by-line analysis of early inter-
views is used on subsequent interviews to test preliminary 
assumptions.34 Interviews were recorded and transcribed 
in full. Reviewers agreed on identified codes and themes. 
To maintain confidentiality, all names reported are pseud-
onyms and identifying data have been excluded.
Participants
Twenty participants agreed to participate in the in-depth 
interviews. Out of the 20 participants interviewed, 19 agreed 
to audio recording, and one participant declined. For the 
latter, detailed field notes and an extensive memo were taken 
for inclusion in data analysis.
ethical approval
Ethical approval for the study was obtained from the National 
University of Singapore Institutional Review Board. Written 
informed consent for participation and recording was obtained 
before the interview started using a participant information 
sheet and consent form. Participants could refuse to answer 
any of the questions and/or discontinue their participation 
in the research at any time.
Results
Participant characteristics
We conducted 20 in-depth interviews with participants 
who met inclusion criteria, and detailed characteristics are 
presented in Table 2. Participants were largely of Chinese 
ethnicity (n=15) with fewer participants from Indian (n=4) 
and Malay (n=1) ethnic groups. Participants were mostly male 
(n=12), with eight female participants. The average age of 
participants was 72.5 years old. The majority of participants 
(n=19) reported a hypertension diagnosis, followed by hyper-
lipidemia (n=16), myocardial infarction/acute coronary syn-
drome (n=8), and stroke/transient ischemic attack (n=5).
Findings: conceptual framework
We presented our findings under themes presented in the 
conceptual framework (Figure 1). First, we examined 
condition and therapy related factors which may impact 
a patient’s adherence. Then we considered the impact 
of health system, patient, and socioeconomic factors on 
medication adherence through the lens of medication access 
using our adapted framework. These were divided into five 
key themes from Levesque et al’s (2013) key dimensions 
of access. First, “approachability” and “ability to perceive” 
demonstrate how patient beliefs about diagnosis, medica-
tion, and adherence impact their ability to perceive the need 
to adhere to their medication. Second, “acceptability” and 
“ability to seek” discuss how a patient’s perception of health 
care facilities as well as their relationship with their health 
care provider might influence the acceptability of medication 
therapy. Third, “availability” and “ability to reach” report 
on the different physical difficulties patients have in reaching 
their health care facility, compounded by factors such as the 
weather, transport, and health care costs. Fourth, “afford-
ability” and “ability to pay” describes the existing health 
financing structures available for patients and their difficulties 
in financing their health care expenses in spite of these struc-
tures. Last, “appropriateness” and “ability to engage” discuss 
how patients adapt and engage with medication therapy, and 
also how they perceive it to be an individual responsibility. 
These findings are summarized in Table 3.
condition related factors
Condition related factors refer to the demands faced by the 
patient as a result of their condition and its symptoms which 
might impact medication adherence. In this context, the 
perception of the seriousness of a condition, in relation to 
Table 2 Participants’ characteristics
Sociodemographic characteristics Total, 
n=20
Ethnicity (n=20)
chinese 15
indian 4
Malay 1
Gender (n=20)
Male 12
Female 8
Age (years) (n=20)
61–70 7
71–80 8
81–90 4
Missing* 1
Mean (n=19) 72.5
Cardiovascular conditions
hypertension 19
hyperlipidemia 16
Myocardial infarction/acute coronary syndrome 8
stroke/transient ischemic attack 5
Number of prescribed chronic medications (n=20)
1–4 4
5–9 7
10 and above 3
Missing* 6
Mean number of prescribed medications (n=14) 6.5
Note: *One patient began the survey process but did not wish to complete the 
process leaving missing demographic details.
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other conditions, has an influence on a patient’s adherence 
to medication therapy.
seriousness of condition
Some patients expressed that they choose which medication 
to take based on how serious they perceive their condition 
to be. When asked about the importance of taking medica-
tion, Sue shared that,
Respondent: Some people they’re not taking it on purpose. 
I don’t take some of my medication too. We take only the 
important medicine and don’t take those that we feel aren’t 
important. [ID020_F_71-75_chi]
Table 3 Summary of key findings
Factor Theme Patient quotes
condition 
related factors
seriousness 
of condition
respondent: some people they’re not taking it on purpose. i don’t take some of my medication too. We 
take only the important medicine and don’t take those that we feel aren’t important.
[iD020_F_71-75_chi]
Therapy related 
factors
Difficulty in 
managing 
medication regimen
interviewer: That’s quite a lot to take twice a day.
respondent: Actually before that i was taking about 11 different medications. Then i used to get stomach 
upset and gastric. so they reduced them, i told them i can’t take it.
interviewer: how long ago was that? 11 sounds like a lot.
respondent: At the beginning there was 14, when i was in the hospital. Then i told them i can’t take so 
many, so they reduced it. [iD007_M_61-65_chi]
side effects Because i take this one, it doesn’t have side effect. if there’s side effect, i don’t take. some people take 
medicine and have side effect, then no […] no side effect is okay. [iD006_M_81-85_chi]
Approachability 
and ability to 
perceive
Beliefs about 
diagnosis
When I first did the test after a hot day, the readings were very high and they asked me to start on 
medications […] i sleep on a bed which has a heating function. On top of that i went into the hospital 
during a hot day and i felt very dehydrated. Then when they checked my blood pressure, it was very 
high. They started me on these medications then. To think about it, i was silly before. now before i take 
measurements at the hospital, i drink some water and try not to go on a hot day.
[iD005_F_81-85_chi]
Beliefs about 
medication
interviewer: if you feel that way, why do you still take your medicine?
respondent: Because i must check my high blood pressure, diabetes, heart, everything i must, 
the medicine can help. i so long now my life means the medicine [is working].
[iD013_F_61-65_chi]
Beliefs about 
adherence
You know medicine you cannot forget. That’s why some of them they get stroke all these. They forget 
their medicine. [iD012_F_71-75_mal]
Acceptability and 
ability to seek
Perception of 
health care facilities
i feel like just going to [private clinic], i don’t feel like going to the public hospital anymore, as they give 
me a lot of medications that are not strong, the medicine is really a lot. The private clinic is expensive 
but the medication they give is stronger and more effective. My husband keeps telling me to change to 
private clinic, my friend also went to private clinic and had a decrease in amount of medicine. Personally 
i also feel like changing to private clinic, as there’s really too much medication given in the polyclinic. 
[iD020_F_71-75_chi]
Patient–provider 
relationship
Because the doctor asks me to take, then i have to take. i never stop, i only stop for this one. 
[iD006_M_81-85_chi]
Availability and 
ability to seek
Physical difficulties sometimes one week i have to go back for blood test, another week for the doctor consult, and i don’t 
want to return twice, but the person said there is no other way. But i travel to the consults or blood test 
by walking, and it is troublesome for me to take public transport over [mentions that it is troublesome 
to cross the overhead bridge]. if it rains then i will not go for the appointments as i will get drenched.
[iD005_F_81-85_chi]
Affordability and 
ability to pay
Health financing 
structures
it’s okay now. After i got the pioneer [generation] card, i have another subsidy […] but i cannot recall 
the name. It also help provide financial aid for health care services.
[iD005_F_81-85_chi]
Difficulties in 
financing health 
care expenses
Yes. [my children] give me some money every month. I think it’s fine. They have families to take care of. 
We cannot ask for too much from them.
[iD001_M_71-75_chi]
Approachability 
and ability to 
perceive
Forgetfulness and 
adaptations
Every morning when I come for breakfast, I take my box of medicine. How can I forget? So all the five 
items are here. so i choose the one i need to take, okay i take and put it back. At night, before i sleep, 
you want to see?
[iD018_M_76-80_chi]
individual 
responsibility
since the medication is meant for yourself, then you need to manage it yourself as well.
[iD009_M_76-80_chi]
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Some patients reported prioritizing certain illnesses over 
others. In our study, patients’ perceived high cholesterol to 
be less serious compared to other conditions. Some patients 
thus chose not to take cholesterol medication, as Patsy 
explained,
Interviewer: So you believe in taking medications for 
more serious illnesses? But when it comes to minor ill-
nesses […]?
Respondent: Like me, mine are not that serious, so 
sometimes I can don’t take them. Especially the cholesterol 
medication. Although the doctor says it’s okay to take them. 
What if something happens? […] So for serious illnesses, 
take your medication. But for minor ones, as long as you 
follow-up, it’s okay. [ID004_F_66-70_chi]
Thus, patient perceptions of the seriousness of ASCVD 
and their risk factors in relation to their other illnesses 
had some impact on their perceived need to adhere to the 
medication.
Therapy related factors
Therapy related factors describe the difficulties patients face 
in managing their complex medication regimens and different 
aspects of treatment (ie, treatment changes and side effects). 
In this context, it refers to the difficulty a patient faces in 
managing their medication regimen and the experienced side 
effects from prescribed medication.
Difficulty in managing medication regimen
Previous literature has demonstrated that patients with 
ASCVD tend to have multiple co-morbidities which require 
a complex medication regimen to manage effectively.9,35 
For patients, this could result in polypharmacy which may 
impact medication adherence.20 For some patients like Heng, 
having to manage multiple different medications impacted 
their adherence:
Interviewer: That’s quite a lot to take twice a day.
Respondent: Actually before that I was taking about 
11 different medications. Then I used to get stomach upset 
and gastric. So they reduced them, I told them I can’t take it.
Interviewer: How long ago was that? 11 sounds like 
a lot.
Respondent: At the beginning there was 14, when 
I was in the hospital. Then I told them I can’t take so many, 
so they reduced it. [ID007_M_61-65_chi]
However, some patients reported no problems manag-
ing a complex medication regimen, for example, Seng who 
despite having polypharmacy, only needed to take medica-
tion once a day:
Interviewer: Do you feel confused about so many types 
of medicine?
Respondent: It’s just once a day! It doesn’t really 
take up a lot of time. It can be done in about 5 minutes, 
not more than 10 minutes. I don’t ask for anything else. 
[ID001_M_71-75_chi]
For some patients, polypharmacy was not the only dif-
ficulty faced when having a complex medication regimen. 
Sue expressed that she struggled with changes made to 
her medication regimen, and this was compounded by the 
lack of support given by health care professionals to take 
medication:
Interviewer: Did they explain how to take the medications?
Respondent: Yes, this one eat half hour within meals, 
this one take only when eaten food, this one for morning. 
This medicine should be morning medicine, but I don’t 
take it anymore.
Interviewer: Why?
Respondent: This medicine at the start when he told 
me to stop eating it, then I forgot how to take it when it 
resumed, then they didn’t explain to me how to take it again. 
[ID020_F_71-75_chi]
experience of side effects from 
prescribed medication
Several patients reported that their side effects, as a result 
of taking medication, impacted their motivation to adhere to 
their medications. For example, Tim explained,
Because I take this one, it doesn’t have side effect. If there’s 
side effect, I don’t take. Some people take medicine and 
have side effect, then no […] No side effect is okay. 
[ID006_M_81-85_chi]
For some patients, their willingness to bear with the side 
effects of a medication is dependent on their perception of 
the severity of their illness. Devi reported,
Interviewer: So you mentioned that you are not taking the 
cholesterol medication?
Respondent: Yeah. I am not taking it.
Interviewer: Why is that the case?
Respondent: As long as my readings are fine.
Interviewer: As long as the readings are okay.
Respondent: You know why? Sometimes it gives you 
aches in your bones. It starts to hurt. [ID011_F_61-65_ind]
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Access related factors
Below we reported the results for the five access dimensions 
with their corresponding abilities from the perspective of 
the patient (Figure 1). We grouped the different factors of 
accessibility with their corresponding ability as seen in the 
framework posited earlier together, as the same theme, as 
we believe discussing them separately would posit them as 
separate points when they actually work in tandem to impact 
patient adherence.
Approachability and ability to 
perceive
Approachability and the ability to perceive refer to the ability 
of patients to identify the importance of adhering to their 
medication regimen, and having the necessary information to 
do so. In this context, we described how patient beliefs about 
diagnosis, medication, and adherence impact adherence.
Beliefs about diagnosis
Some patients had doubts that they even had conditions they 
were diagnosed with and given medication for.
When I first did the test after a hot day, the readings were 
very high and they asked me to start on medications […] 
I sleep on a bed which has a heating function. On top of 
that I went into the hospital during a hot day and I felt very 
dehydrated. Then when they checked my blood pressure, 
it was very high. They started me on these medications 
then. To think about it, I was silly before. Now before I take 
measurements at the hospital, I drink some water and try 
not to go on a hot day. [ID005_F_81-85_chi]
Mei believed that her high blood pressure reading was 
caused by the conditions in which their test was taken and 
was not entirely convinced that she had hypertension.
When asked if he had high blood pressure, Tim 
responded,
No. No diabetes, no high blood pressure. No more high 
blood pressure. [ID006_M_81-85_chi]
This was despite the fact that Tim had been prescribed 
hypertension medication.
Beliefs about medication
Some patients interviewed believed that there was value 
in adhering to their medication regimen and that it was the 
reason why they were still alive.
Interviewer: Okay that’s good. So actually do you think the 
medicine helps you with the condition?
Respondent: Of course it helps […] if not I may not 
survive till now. [ID003_F_NA_chi]
Despite this, patients such as Patsy would rather manage 
their condition through diet management due to the perceived 
side effects of medication.
Interviewer: Why don’t you take the cholesterol medication?
Respondent: Because both my niece and my elder sister 
are nurses. My sister told me that if I take a lot of these 
cholesterol medication, it will affect my kidneys. Because 
I have cancer, so I want to avoid taking these. I avoid oily 
and fatty foods. I try to control my cholesterol that way. 
[ID004_F_66-70_chi]
Some patients, like Tim, do not see the need to take sev-
eral types of medication for one illness. In trying to justify 
why he had stopped taking enalapril for his blood pressure, 
Tim asserted that:
[this is] quite the same […] this one is for the heart, high 
blood pressure […] this one is quite the same, high blood 
pressure […]. [ID006_M_81-85_chi]
For Tim, the perception that enalapril is the “same” as 
other medication for his high blood pressure impacted his 
adherence to his medication regimen.
Beliefs about adherence
Patients interviewed had several beliefs about adherence 
which impacted how they perceived the need to be adherent. 
Firstly, some patients did not feel the need to be constantly 
adherent to their medication regimen, and this was dependent 
on how they feel and their readings. Devi perceived that there 
is no need to adhere to cholesterol medication if a patient’s 
cholesterol is only borderline and took a self-management 
approach to medication adherence,
Interviewer: So the doctor has been giving you the cho-
lesterol medication but you have not been taking it? Then 
[…] diabetes?
Respondent: That one is only a few months. They said, 
“oh your case is borderline” – I said, “borderline”? Then 
why are you giving me […]? After that, they said, “Normal, 
normal, but this medicine still carry on”.
Interviewer: Did you tell the doctor that you didn’t take 
or didn’t want to take the cholesterol medicine?
Respondent: No, as long as my reading is normal I’ll 
keep quiet. If it goes up I’ll tell them. If they try to increase 
my dosage then I will tell them I haven’t been taking it. 
[ID011_F_61-65_ind]
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She would only disclose she had not been adherent 
when her reading goes beyond borderline. Dan echoes this 
and sometimes does not feel the need to take his cholesterol 
medication when he feels alright,
Okay, to be honest, blood thinner, I almost take every day. 
So sometimes the idea just come “Hey, I think I am okay 
what, so don’t need to take everyday”. You know what 
I mean? But mostly, blood thinner I try to take regularly. 
Cholesterol, sometimes I miss. [ID016_M_61-65_chi]
Secondly, several patients explained that they were 
adherent to their medication because they are afraid of the 
complications that will result from non-adherence. Ben 
explained that he knew being non-adherent to his medicine 
could lead to a stroke and was afraid of it:
Interviewer: Do you think it’s important to control your 
blood pressure?
Respondent: Yes, otherwise things happen.
Interviewer: What kind of things?
Respondent: Things like stroke. [ID019_M_81-85_chi]
Kim shared that she was motivated to adhere to medica-
tion as she is worried about death which could potentially 
result from not managing her condition:
Because I’m scared to die, it motivates me to eat my medica-
tion, without even any reminder. [ID008_F_71-75_chi]
Third, some patients felt that being non-adherent would 
make the whole process of seeking care and seeing a physi-
cian pointless.
I trust [doctors] so I won’t dare to not take the medication. 
If you don’t take the medication, then you might as well 
don’t see the doctor. It’ll be a waste of everyone’s time. 
[ID009_M_76-80_chi]
Why you want to see doctor if you don’t take the medi-
cine? Right? If you want to see the doctor that means you 
want to get well and to get well, you have to eat the medicine, 
otherwise, how can you get well? [ID018_M_76-80_chi]
Both Steve and Teo asserted that non-adherence will not 
only render appointments with the physician pointless but 
also prevent patients from managing their condition.
Acceptability and ability to seek
Acceptability and ability to seek refer to the sociocultural 
factors which enable patients to have the capacity to seek and 
accept different aspects of the medication therapy impacting 
their adherence. Important facets of acceptability and the 
ability to seek include individual health system preferences, 
as well as the patient–provider relationship.
Perception of health care facilities
Some patients mentioned that the acceptability of medication 
therapy was impacted by perceptions of the services provided 
by different sectors of the health system, namely, private or 
public health care. For example, Sue expressed that:
I feel like just going to [private clinic], I don’t feel like 
going to the public hospital anymore, as they give me a lot 
of medication that are not strong, the medicine is really a 
lot. The private clinic is expensive but the medication they 
give is stronger and more effective. My husband keep tell-
ing me to change to private clinic, my friend also went to 
private clinic and had a decrease in amount of medicine. 
Personally I also feel like changing to private clinic, as 
there’s really too much medication given in the polyclinic. 
[ID020_F_71-75_chi]
For some patients these perceptions stem from previous 
experience with providers from different sectors (ie, pro-
viders in public and private health care facilities). Kim 
explained that,
At the polyclinic they don’t care so much how serious things 
are. They just ask a few questions and ask me to collect my 
medicine. It’s better at the hospital. Last time, my daughter 
likes to bring me to private hospitals. They’re very good, 
but too expensive, [private hospital]. Their medications are 
very good but very expensive. The medication is good, no 
problems even after my surgery. [ID008_F_71-75_chi]
Patient–provider relationship
Key to the acceptability of a medication regimen is the 
engagement between health care professionals and patients, 
and the ability of health care professionals to deliver care 
acceptable to the patient. Many patients described encounter-
ing multiple non-physician health care professionals during 
their engagement with the health system, where different 
tasks in the care process are shared among health care profes-
sionals such as pharmacists, nurses, and care coordinators. 
Many patients described their encounters with these health 
care professionals positively with regard to helping them 
adhere to their medication. For example, when asked about 
the help she receives in taking medication Xue said,
Yeah, yeah. My pharmacy, they tell me. The pharmacy, they 
help me a lot. Sometimes, I don’t know the medicine name. 
I don’t know until now, I don’t know the medicine name, 
but only I know morning, up. Night, up. “Okay, morning 
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I must take. Night, also, I must take.” Same medicine. So I 
don’t know the name but the pharmacists say, “This one, 
half ah madam,” and then they tell me of what medicine. 
So sometimes I see the words. This one is half tablet, one 
tablet, I can see the words. [ID013_F_61-65_chi]
Some patients, such as Heng, have a care coordinator who 
helps them to adhere to their medication and manage their 
condition through medication reconciliation and counseling. 
Heng’s experience with his care coordinator has been very 
positive. When asked about whether the care coordinator has 
helped him, Heng responded,
Yes, it helps because it’s more personal care than a general 
[one] […]. [ID007_M_61-65_chi]
Beyond the personalized care that a care coordinator 
provides, Heng believes that some care coordinators are more 
knowledgeable than the doctors, and should be trusted as they 
have been at the clinic longer than the doctors.
Some of them have been there 5–6 years, but the doctors are 
maybe there for 1–2 years. Sometimes when the doctors say 
something, they will correct them, like if it’s not allowed 
or like that. [ID007_M_61-65_chi]
While trust in non-physician health care professionals 
is important in ensuring the acceptability of health services 
to ensure patients adhere to medication, the relationship 
between a patient and physician is also crucial in enabling 
medication adherence, and consequently condition manage-
ment. In response to a question about whether Mei Ling takes 
any form of alternative medicine, she responded that:
Very little. Because my liver is not good, I’m afraid of 
mixing them. The doctor told me before as well, to stick 
to my medication, and he knows my condition well. My 
doctor talks to me like a friend. [ID005_F_81-85_chi]
For Mei, the relationship she has with her physician 
is described to be one of friendship which in turn encour-
aged her adherence to her medication regime. Echoing this, 
several patients interviewed talked about the trust they had 
in their doctors and the importance of a relationship with 
them. However, not all patients had a sole primary physician. 
Samuel demonstrated a desire to see the same doctor, and 
the preference for a doctor to “know” him, but health system 
changes have made this difficult.
In the polyclinic every appointment is with a different 
doctor. Sometimes I try to ask to see the same doctor, 
because the doctor knows me, but the last two years it has 
been a different doctor. There was a stage about 5 or 6 years 
ago when I used to see the same doctor, I tried to make 
appointments to see the same one. In order to do that, I don’t 
make an appointment early […]. I go and then ask on the 
spot. Because actually I would rather see the same doctor 
every time. At least he or she can recognize me. If I am 
booking by phone or through the App, it’s an automated sys-
tem. You can get Tom, Dick or Harry. Sometimes they will 
give a different result or a different diagnosis or whatever. 
This is what I think. [ID015_M_61-65_chi]
Beyond fostering a friendly and trusting relationship, 
doctors are in the position to make certain types of treatment 
acceptable for the patient. For example Teo explained,
That one time they said I have a stroke, I have to accept the 
fact, I can’t run away from it and so, they begin to prescribe 
medicine for me. Now the interesting thing is that one of 
the senior doctor was talking to me, invite me to join the 
group to test a new drug for diluting the blood circulation. 
I was quite scared. Because of my reaction, the doctor told 
me, “Don’t worry. We are not doing any harm to you. What 
we are doing is actually for your own good. But we think 
it is good.” The way he said it was so confident so okay, 
I accept it. [ID018_M_76-80_chi]
For some patients, such as Siew and Patsy, this trust in 
physicians might not stem from “friendship” but should rather 
be seen as a given due to the power dynamic between doctors 
and patients. For example, Siew explained that:
Interviewer: Why do you follow the instruction of doctors?
Respondent: Because I know my own problem well […] 
so if I see a doctor and don’t trust him, then why should I 
go and see? [ID003_F_NA_chi]
Interviewer: Since you have said you shared a lot of 
things with your doctor, do you have a good relationship 
with your doctor?
Respondent: Yes it has to be. I will tell the doctor 
everything.
Interviewer: So you trust your doctor?
Respondent: Yes, I have to. Or else? You should always 
follow-up with your doctor after taking your medications. 
[ID004_F_66-70_chi]
This sense of unquestioned trust in physicians also 
manifested in how patients perceived the physician’s 
instructions.
I can’t remember what they’re [medication] for. The doctor 
give me, so I eat. [ID002_M_81-85_chi]
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Seng even expressed that if a doctor says something then 
there is “no choice” but to accept medication therapy.
They said I have to take medicine for […] what is that 
called […] it’s high blood pressure. The doctor told me 
to take medicine. No choice, I started taking it and took 
it for a few decades already, since I was 40-something. 
[ID001_M_71-75_chi]
Despite this, some patients such as Patsy still choose not 
to adhere to medication given to her, and would rather not 
tell the doctor about it for fear of being scolded.
Interviewer: How about your cholesterol?
Respondent: It varies. Sometimes it’s high, sometimes 
it’s low. Because sometimes I don’t take the medication. 
You see, this cholesterol medication was given to me in 
March, and I still have so much left over. If I show the 
doctor, he/she is going to scold me. So I won’t tell the 
doctor. [ID004_F_66-70_chi]
Availability and ability to reach
Availability and ability to reach relates to the factors which 
give people the capability to reach the medication they need 
when they need it. These include physical access, mobility, and 
understanding of the health services available. Most patients 
were able to physically access health services; however, some 
pointed out that the journey to health care facilities could 
be difficult due to their age and other physical difficulties.
Interviewer: Do you walk there?
Respondent: No, I take transportation [bus]. It’s 
too far to walk. I cannot […] my legs are not well. 
[ID001_M_71-75_chi]
Mei noted that it is sometimes difficult for her to get 
to health care facilities for medical appointments due to 
inclement weather, and this at times discourages her from 
wanting to go for her appointment to see the doctor.
Sometimes one week I have to go back for blood test, 
another week for the doctor consult, and I don’t want to 
return twice, but the person said there is no other way. But 
I travel to the consults or blood test by walking, and it is 
troublesome for me to take public transport over [mentions 
that it is troublesome to cross the overhead bridge]. If it 
rains then I will not go for the appointments as I will get 
drenched. [ID005_F_81-85_chi]
Kim pointed out that her ability to pay for health services, 
and desire to not burden her children, had an impact on her 
ability to seek certain types of medication,
I was seeing private hospital, but my friends say that 
I shouldn’t burden my daughter with the fees. Initially 
I went to a polyclinic and they didn’t have the medicine, 
as it’s an expensive medicine. Then my friends brought 
me to Clementi polyclinic, which is a polyclinic for richer 
people, and they really have the medicine there. But it’s still 
expensive, not cheaper by a lot. [ID008_F_71-75_chi]
Affordability and ability to pay
Affordability and ability to pay refer to the structures in 
place which impact an individual’s economic capacity to 
engage with health services and obtain medication. They 
ensure a patient is financially able to adhere to a medication 
regimen prescribed, without having grave impact on daily 
necessities. In this context, we described the health financing 
structures which make medication affordable for patients, 
and their ability to pay for health care expenses in light of 
these structures.
Health financing structures
Most patients interviewed found medication prescribed for 
ASCVD and their risk factors to be affordable and had no 
issues obtaining medication. This is largely due to the avail-
ability of different schemes and subsidies initiated by the 
government. When asked if she felt medication was afford-
able Mei responded,
It’s okay now. After I got the pioneer [generation] card, 
I have another subsidy […] but I cannot recall the name. 
It also help provide financial aid for health care services. 
[ID005_F_81-85_chi]
Several patients interviewed had a Pioneer Generation 
(PG) or Community Health Assistance Scheme (CHAS), like 
Mei, and stated that it had helped them greatly in making 
their health care and medication expenditure affordable.
Difficulties in financing health care expenses
Although patients generally found that they could afford their 
medications, some patients shared that the subsidies from 
financing structures were necessary for them to pay for any 
of their medical expenses at all. Li said that without health 
care and social financing they are unable to pay for any of 
their health care expenses.
Interviewer: Without this [Comcare] card, how much would 
the expenses be?
Respondent: We wouldn’t be able to afford [health care 
expenses] at all. [ID014_M_71-75_chi]
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Patients, such as Siva, who were not eligible for Comcare 
and had to co-pay for their medication also described difficul-
ties paying out of pocket despite subsidies available.
Interviewer: Do you have Medisave for these?
Respondent: I have problems with Medisave now. They 
give me something like $300 every three months. The other 
time I went for something and now it’s all gone. So I must 
wait till January for them to top-up $300.
Interviewer: So you have to pay out of pocket now?
Respondent: Yes. I asked my son to help […] Subsidize 
is have. [ID010_M_71-75_ind]
Siva is still required to pay out of pocket for medication, 
and has to count on his son to help him with the expenses. 
Several patients mentioned that their family members 
helped them to manage the financial burdens of obtaining 
medication.
Yes. [My children] give me some money every month. 
I think it’s fine. They have families to take care of. We cannot 
ask for too much from them. [ID001_M_71-75_chi]
As with Seng, there was a sense among patients inter-
viewed that they did not want to be an economic burden on 
their family members and be prioritized over other family 
interests.
Appropriateness and ability to engage
Appropriateness and ability to engage relate to the capacity 
and willingness of patients to participate in their medica-
tion regimen to meet their treatment needs. In this context, 
it refers to the adaptations patients make to their daily lives 
to mitigate forgetting their medication, and their assertion 
that there is an individual responsibility to engage with their 
medication regimen.
Forgetfulness and adaptations
For some patients, a key reason for lack of engagement with 
their medication plan is forgetfulness. Patients had several 
reasons for forgetting their medication, for example Peter 
reported forgetting medication after being distracted by 
housework.
Interviewer: Why do you forget?
Respondent: Housework, etc. Sometimes the time for 
medication has passed. I forget about once or twice a week. 
[ID002_M_81-85_chi]
Patsy forgets when she travels to her daughter’s house 
on the weekends to help with child care,
I tend to forget my medications in the morning on weekends. 
I take care of my grandchildren, I go to Woodlands where 
my daughter stays, and so I forget. [ID004_F_66-70_chi]
Sue claimed that she does not forget and knowingly 
chooses not to adhere to her medication as she finds taking 
it to be inconvenient.
Interviewer: Do you forget to take your medication?
Respondent: No. But if I go out, I won’t bring and eat 
it. It’s very troublesome to take it when I’m on the bus or 
MRT [tube system in Singapore]. I’ll just miss taking it. For 
instance, I went to Ipoh Malaysia the other day, I brought 
my medicine but I didn’t take it for two days, as it’s too 
troublesome. As we sometimes take car late in the night so 
it’s troublesome taking medicine, also sometimes simply 
forget after eating meals. [ID020_F_71-75_chi]
For patients that forget to take their medication, some 
reported that health care professionals are aware and do 
provide advice on how to re-engage with their medication 
regimen. For example, Peter consults his doctor about what 
to do when he misses a dose.
Interviewer: Have you asked the doctor if it’s okay to take 
the medication later?
Respondent: The doctor said it’s okay to miss a dose, 
and just continue the next day. [ID002_M_81-85_chi]
The doctor recommended Pasty use a pillbox to help her 
remember to take her medication, and it worked for her.
Respondent: The doctor recommended me to put the 
medicine into a pillbox as I forget to take my medication 
often. Putting the medicine in a pillbox simply serves as a 
reminder that I forget to eat.
Interviewer: How long have you used this pillbox?
Respondent: One year. It helps with my memory, so I 
won’t keep forgetting to take my medications. And since 
the medication is already packed, so I won’t forget to eat 
one or two medication. [ID004_F_66-70_chi]
The use of a pillbox was effective in helping several 
patients such as Devi remember to take their medication and 
preventing overdose.
Interviewer: Do you feel [the pillbox] helps?
Respondent: Yes. Sometimes you forget! “Did I take the 
medication or not?” and you look into it. If you look at it 
and it has disappeared that means you have already taken it. 
Also, if I am not sure then I totally avoid it because I don’t 
want to have an overdose. [ID011_F_61-65_ind]
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Several patients were able to actively engage with their 
medication regimen, adapting their daily lives and creating 
habitual processes to ensure they adhere to medication.
I usually put the pills down here [table] during the meal, and put 
them up there after taking the pills. [ID001_M_71-75_chi]
Yes. I place it on the table so that I know I need to take 
it tomorrow morning. Once I’ve taken it, I place it back in 
the cupboard. [ID002_M_81-85_chi]
I place it here. In the morning, I go for my exercise. 
When I return home after breakfast, I will take the medica-
tions first before doing anything else. It has become a habit 
so I won’t forget. [ID009_M_76-80_chi]
Some patients are more innovative, Xue repurposed a 
toolbox to be used as a pillbox.
No, I go and shop the […] Jurong West got one shop. Then, 
I go see this kind of [tool] box. My friends tell me it can cut, 
put with the needle and the thread then I said, “Hey, can put 
the medicine in also what”. [ID013_F_61-65_chi]
Li felt that pillboxes did not work for him as he always 
lost them, he decided to pack his medication into little plastic 
packets so he could just open one and take all the necessary 
medication for the day. When asked about how he came up 
with this idea, Li responded that,
In the past, we used to use the pillbox. But somehow the 
whole box would go missing, as I was working during 
that time. So it’s easier to remember this way, even after I 
stopped working. We can go back to the box, but we already 
lost it so we don’t want to buy it. [ID014_M-71-75_chi]
individual responsibility to engage
When asking Patsy if anyone helps them manage her medica-
tion, she responded that,
It’s better if I do it myself, since [the helper] doesn’t 
know what medication I take […]. I feel that since 
it’s my medication, I should take responsibility for it. 
[ID004_F_66-70_chi]
This sentiment was echoed by several patients interviewed, 
and many of them did not feel like they needed help managing 
their medication since it should be an individual responsibility 
to engage with their treatment regimen.
Since the medication is meant for yourself, then you need 
to manage it yourself as well. [ID009_M_76-80_chi]
Discussion
This qualitative study explored the different factors influ-
encing medication adherence in the primary and secondary 
prevention of ASCVD in Singapore. To better contextualize 
our findings it is necessary to consider larger health system 
factors relevant to Singapore, primarily the ubiquity of 
affordable and accessible health care. Singaporeans have 
access to largely subsidized care offered in polyclinics (gov-
ernment subsidized general practice clinics), private GPs, and 
tertiary care facilities for primary care and chronic condition 
management. Further, within the primary care setting, doctors 
regularly prescribe a few months’ worth of medications thus 
enabling ease of access to medications.
Singapore has a “no free lunch” philosophy to health 
care financing, where subsidies and various schemes for 
the management of chronic conditions are widely available 
but Singaporeans are expected to co-pay part of the cost to 
ensure “shared responsibility”.36,37 A key feature of health 
care financing in Singapore is the use of an individual 
medical savings scheme administered by the state, known 
as Medisave, in chronic disease financing. Medisave helps 
individuals put aside part of their income into Medisave 
accounts to meet future health expenses they might have, as 
a way of helping Singaporeans to be individually responsible 
for financing their health care.37,38 In addition to Medisave, 
many patients interviewed cited having the PG, CHAS, and 
Comcare card. The PG card grants subsidies to public health 
care services and medication to seniors aged 65 and above 
in 2014. The CHAS card allows for Singaporeans in low- to 
middle-income households to receive subsidies for medical 
care in participating primary care facilities. Comcare is a 
social assistance scheme directed at low income Singaporeans 
and their families. These financing structures ensure that the 
majority of Singaporeans have access to relatively affordable 
medication, particularly for chronic diseases, such as CVD, 
which carry a heavy economic burden.
Participants reported condition and therapy related factors 
impacting their adherence. Some patients perceived ASCVD 
and their risk factors to be of lower priority relative to their 
other illnesses, which had an impact on their perceived need 
to adhere to the medication regimen. This is consistent with 
previous evidence demonstrating that a patient’s perception 
of a disease’s severity could have implications on their medi-
cation adherence.39 It was also found that some participants 
chose not to adhere to their medication due to the complexity 
and possible side effects of their medication regimen. Patients 
who were non-adherent to complex regimens tended to 
experience polypharmacy, which for several patients led 
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to non-adherence. This runs parallel to previous work done 
in the literature and has been extensively shown to impact 
adherence in several contexts.12,18–21,40–47
From the perspective of access, and considering the 
tenets of accessibility, many patients described the accept-
ability of a medication regimen to be highly contingent on 
the patient–provider relationship as well as their perception 
of different health care facilities. Some patients interviewed 
believed that medication obtained from health care establish-
ments in the private sector are “better”, as compared to public 
health care facilities. For some patients this impacted their 
acceptability of, and possibly their adherence to, a medication 
regimen. For many patients their adherence to medication 
was largely contingent on their trusting relationship with 
their health care professional. However, for some patients 
this trusting relationship with providers and their medica-
tion regimen was unquestionably accepted. This hinted at a 
possible underlying power asymmetry which underlay the 
trust relationship between patient and physician, and caused 
some patients to be non-adherent without telling their pro-
vider about it, feeling the need to hide their non-adherence. 
Similar work done elsewhere also demonstrated that the 
rapport patients have with their health care provider, has an 
impact on their adherence.31,43,48
Another tenet of accessibility expressed was affordabil-
ity, and this could be discussed in tandem with a patient’s 
ability to pay. Most patients shared that medication was 
generally made affordable due to a number of subsidies 
and schemes, which decreased the amount they needed to 
co-pay for medication. Some patients continued to struggle 
to pool finances among themselves and their families to 
pay for medication in spite of financing structures made 
available within the health system. The ability to pay for 
care has been shown to have a direct impact on patients’ 
ability to manage their chronic conditions, Wee and Koh 
(2012) have shown that awareness, treatment, and control 
of CVD risk factors, such as hypertension, were poorer 
in Singaporean patients with low socioeconomic status.49 
Furthermore, some patients also felt that their ability to 
seek medication they want was impacted by their ability 
to pay for it. Evidence in the literature has clearly shown 
that costly health system options, coupled with insufficient 
financial resources, could negatively affect a patient’s 
ability to seek medication.14,31,40–42,50 A patient’s ability to 
seek the medication they want is integral in order for the 
patient to adhere to medication. Other studies have also 
reported on non-adherence attributed to fragmented health 
care provision, and the corresponding need for accessible, 
continual, and coordinated health care services to facilitate 
adherence.15,22,51,52 Hence, there is a need for more innovative 
funding structures for patients who lack the ability to pay 
for health care services and medication.
For many patients their ability to perceive the need to be 
adherent to a medication regime, was founded on their belief 
of diagnosis, treatment, and adherence. Several patients did 
not believe that they had the risk factors of ASCVD, such 
as hypertension. These patients were convinced that their 
diagnosis of these risk factors were in fact due to the condi-
tions in which they were tested (ie, stresses of traveling to 
health care institutions, or hot weather, causing high blood 
pressure readings) rather than actually having the condition. 
Many patients had the ability to perceive that it is important 
to adhere to a medication regimen due to either the believed 
efficacy of medication or the fear of potential complica-
tions resulting from unmanaged ASCVD risk factors. These 
findings mirror results from other studies that evaluated 
medication adherence among patients with CVDs.43–47 We 
also observed a few participants displaying “self-monitor-
and-review” and “risk-benefit evaluation” behavior, similar 
to qualitative findings from a systematic review, in which 
participants took medication only when symptoms ensued.45 
These behaviors illustrate a dynamic interplay of beliefs and 
perceptions in patients’ thought processes that can be framed 
under behavioral models such as the Health-Belief Model.53 
In making decisions regarding adherence, “self-monitor-and-
review” constitutes an interplay of perceptions regarding 
disease severity and therapy benefits, while “risk-benefit 
evaluation” goes further in accounting for perceived therapy 
risk (or barriers).53
While some patients, at times, forgot to take their medica-
tion, many were able to engage with their medication regimen 
concurring with other studies that associated forgetfulness 
with non-adherence.51,54,55 Most patients either used pillboxes, 
or developed their own everyday habits to remind them to 
take medication and ensure that they were able to be adherent 
to the medication regimen. Patients demonstrated that this 
willingness to engage with their medication regimen stems 
from the importance they place on medication adherence 
being an individual responsibility. Similarly, self-efficacy 
has been identified as a key adherence facilitator in prior 
studies.40,43 This willingness to engage independently, opens 
the door for health care providers to develop innovative 
approaches, such as mHealth, to help ASCVD patients man-
age their chronic conditions. However, these interventions 
will need to consider larger health system access factors 
pointed out earlier.
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recommendations
Based on the synthesized framework proposed earlier, 
our findings recommend that future interventions, such as 
those using mHealth, which aim to encourage medication 
adherence among patients who have ASCVD and its risk 
factors need to consider four key factors; patient percep-
tions; patient-centeredness; medication affordability; and 
the patient–provider relationship.
Patient perceptions
Interventions have to tackle patient perceptions of health 
systems, diagnosis, medication, adherence, and possible 
complications of ASCVD. Our findings point to how these 
perceptions impacted a patient’s ability to perceive the need 
to be adherent to their medication and the acceptability of 
medication regimens. Adherent behavior arises from a com-
posite of perceptions; therefore strategies, including mHealth, 
aiming to improve adherence via changing perceptions are 
essential, and should be guided by behavioral models that 
approach the topic from multiple perspectives.53
Patient-centeredness
Our findings show that patients do engage with their 
medication regimen and believe that there is an individual 
responsibility to do so. Although self-management might 
risk impacting a patient’s adherence to medication therapy, 
our findings show that many patients adapted their everyday 
activities to accommodate and ensure medication adher-
ence and took clear ownership of taking medication. This 
advocates a push for patient-centered care interventions 
which facilitate adherence through building self-efficacy 
and stronger support networks via patient empowerment 
and engagement.56,57 Elsewhere, patient-centeredness has 
demonstrated potential in promoting therapy appropriate-
ness for chronic disease management, and consequently, 
adherence.58–60 This push for patient-centered care is sup-
ported by our findings that medication regimen complexity 
and side effects negatively impact a patient’s ability and 
willingness to be adherent, pointing to the importance of 
personalized care, a key component to patient-centered care. 
Hence, future interventions targeted at medication adherence 
have to be patient-centered, understanding patient concerns 
with regard to their medication and conditions.61
Medication affordability
Future interventions should look at decreasing patient co-
payments as much as possible. While Singapore’s health 
care financing structures allow for patients to affordably 
have access to medication, our findings suggest that some 
patients still have difficulty pulling resources together to pay 
for medication. Furthermore, the evidence of the decrease 
of patient co-payments in order to encourage adherence has 
been widely reported elsewhere.62–65
Patient–provider relationship
A key theme in this study is the relationship between a patient 
and their provider. Our findings show that doctors are trusted 
and their words hold tremendous value to the patients. Many 
patients shared that the foundation of their adherence is their 
trust in the doctor, and the doctors’ words are able to make 
a medication regimen acceptable in the eyes of the patient. 
Hence, future interventions should seek to cultivate a trusting 
relationship between the patient and physician if adherence 
is to be improved, as reported elsewhere.48 We also found 
that non-physician health care professionals such as nurses 
and pharmacists played some role in a patient’s medication 
adherence. Although their role was less pronounced, they 
have important roles in encouraging medication adherence 
among patients.66,67 Future interventions should also look at 
promoting good patient–provider relationships with non-
physician health care professionals.
strengths and limitations
A key strength of this study is the application of a synthesized 
framework which expands our view of medication access, 
and broadens existing understandings of adherence factors. 
Applying qualitative methodology to explore participants’ 
perspectives through in-depth interviews allowed us to 
access participants’ perceptions, beliefs, and experiences, 
which is usually not accessible through quantitative studies.68 
Moreover, this is one of the few qualitative studies, to our 
knowledge, that explored adherence among ASCVD patients 
in Singapore. Our study also included participants from dif-
ferent ethnic backgrounds which added to the diversity of 
experiences captured.
A limitation of this study is the age of our patients who 
were all above 60 years, as such this study was not able to 
capture the views and experiences of younger, middle-aged 
patients taking ASCVD medication. Furthermore, this study 
excluded patients who had physical, cognitive or mental 
deficiencies which prevented them from participating in the 
interviews. Also, patients interviewed largely claimed to be 
adherent to their medication, and this could be inaccurate 
due to it being a self-reported outcome which is prone to 
desirability bias. This bias might have compelled partici-
pants to report more favorably about their own adherence. 
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Finally, further research could focus on understanding the 
bearing of other socioeconomic factors on medication adher-
ence, such as education level or ethnicity.
Conclusion
This study has identified several factors influencing medi-
cation adherence toward ASCVD prevention in Singapore. 
We proposed a framework which expanded on existing 
understandings of medication access, to broaden our insight 
into the factors of medication adherence. We used this frame-
work to explore the different therapy, condition, and access 
related factors which might impact medication adherence 
for patients with ASCVD or their risk factors in Singapore. 
We believe that this framework would be a useful tool for 
exploring the social and access factors which underpin 
interventions, such as those used in mHealth, conceived to 
promote adherence. On the basis of using this framework to 
conduct an analysis in this study, we recommend that future 
interventions consider patient perceptions, advocate patient-
centered care, guarantee that medication is affordable for 
the patient, and nurture good patient–provider relationships.
As populations around the world age at an alarming rate, 
the need to understand what works in managing chronic dis-
ease has become increasingly important. Moving forward, 
future research needs to consider the relevance of existing 
interventions for the “next generation” of patients with 
ASCVD, and develop innovative interventions (developed 
with patients at the center) which are effective for those 
patients. This is particularly important for wealthier nations 
with good access to health care like Singapore, where the 
effectiveness of pharmacotherapy might be heavily contin-
gent on improving adherence levels.14
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